10% Owner · AEON Biopharma, Inc. · AEON Biopharma, Inc. — Pre-Funded Warrant (right to buy)
Side
X
Value
—
Shares
11.24M
Price
—
Executed
Oct 30, 2026
Disclosed
Nov 10, 2026
Disclosure timeline11 days from execution to publication · legal deadline 2 business days
Oct 30 executedNov 10, 2026 disclosed
AEON · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
In-the-money exercise — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing+10 / 15
Disclosed 7 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
AEON Biopharma, Inc. — Pre-Funded Warrant (right to buy)
Ticker
AEON
Shares
11.24M
Price per share
$0
Execution date (reported)
Oct 30, 2026
Owned after transaction
0 shares
Days from execution to publication
11
What this establishes
Daewoong Co., Ltd filed this Form 4 reporting a in-the-money exercise of AEON on Oct 30, 2026. It became public on Nov 10, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
10% Owner
Daewoong Co., Ltdcik:0001985493
Issuer
AEON Biopharma, Inc.cik:0001837607
Revision history · 0
No field has changed since this record was first ingested.
